Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
J. Clin. Oncol 2022 Apr 06;[EPub Ahead of Print], JM Price, HB Mistry, G Betts, EJ Cheadle, L Dixon, K Garcez, T Illidge, Z Iyizoba-Ebozue, LW Lee, A McPartlin, RJD Prestwich, S Papageorgiou, DJ Pritchard, A Sykes, CM West, DJ ThomsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.